市場調查報告書
商品編碼
921947

全球細胞離析市場:成長,趨勢,及預測

Cell Isolation Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

出版日期: | 出版商: Mordor Intelligence Pvt Ltd | 英文 112 Pages | 商品交期: 2-3個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

  • 全貌
  • 簡介
  • 目錄
簡介

本報告提供全球細胞離析市場的相關調查,提供市場機會和趨勢,成長及阻礙因素,各產品·類型·用途·地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 簡介

  • 調查的前提條件
  • 調查範圍

第2章 調查方法

第3章 摘要整理

第4章 市場動態

  • 市場概況
  • 市場成長要素
    • 慢性疾病的盛行率增加
    • 細胞離析的技術進步與創新
  • 市場阻礙因素
    • 細胞離析的嚴格法規與合法性
  • 波特的五力分析

第5章 市場區隔

  • 各產品
    • 消耗品
    • 設備
  • 各類型
    • 動物
  • 各用途
    • 研究所·研究所
    • 生物科技·生物醫藥品公司
    • 其他
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東·非洲
    • 南美

第6章 競爭情形

  • 企業簡介
    • Becton Dickinson and Company
    • GE Healthcare
    • Merck KgaA
    • Thermo Fisher Scientific
    • Bio-Rad Laboratories Inc
    • Terumo CorporationBCT株式會社
    • PluriSelect Life Science UG & Co. KG
    • MiltenyiBiotec
    • Beckman Coulter, Inc
    • STEMCELL Technologies Inc

第7章 市場機會及今後趨勢

目錄
Product Code: 67777

The cell isolation/cell separation market studied was anticipated to grow with a CAGR of 17.2%, during the forecast period. Cell separation/Cell isolation technologies are generally used in the diagnosis of diseases, cellular research, and cellular therapies. The factors such as increasing incidence and prevalence of chronic diseases with an aging population, growing demand for biopharmaceuticals, technological advancement in cell isolation, and increasing stem cell research are driving cell isolation/cell separation market.

According to the World Health Organization (WHO), Cancer is the second leading cause of death globally and is responsible for an estimated 9.6 million deaths in the year 2018. Globally, about 1 in 6 deaths is due to cancer disease. Approximately 70% of deaths from cancer disease occur in low- and middle-income countries. Therefore with the increasing prevalence of chronic diseases and technological advancement and innovation in cell isolation are the key driving factors in the cell isolation market.

Key Market Trends

Human Cell Segment is Expected to Hold a Significant Market Share in the Cell Isolation Market

Human Cell therapy is a type of therapy in which live cells are injected into a patient with cell isolation/separation technique for the treatment of a number of disorders. For example, T-cells are injected into a patient for the treatment of cancer as they are capable of fighting cancer cells during the immunotherapy treatment.

According to the World Health Organization (WHO), Cancer is the second leading cause of death globally and is responsible for an estimated 9.6 million deaths in the year 2018. Globally, about 1 in 6 deaths is due to cancer disease. Approximately 70% of deaths from cancer disease occur in low- and middle-income countries.

Therefore the increasing prevalence of chronic diseases and technological advancement and innovation in cell isolation are the key driving factors in the human cell segment.

North America is Expected to Dominate the Market and Expected to do Same in the Forecast Period

North America is expected to hold a dominating position in the global cell isolation market due to well-established infrastructure for life science research along with a highly organized regulatory structure for the companies focusing on the development of novel treatments.

According to the National Cancer Institute, in the year 2018, an estimated 1,735,350 new cases of cancer were diagnosed in the United States and 609,640 people will die from the disease. Moreover, increasing expenditure on research and development by the private and public players will also augment the growth of this market.

Competitive Landscape

The cell isolation market is fragmented competitive and consists of several market participants. In terms of market share, few of the major players are currently dominating the market. Some players are adopting numerous strategies including acquisitions and collaborations to sustain market competition. Some of the companies which are currently domianting the market are Becton Dickinson and Company, GE Healthcare, Merck KgaA, Thermo Fisher Scientific, Bio-Rad Laboratories Inc, Terumo BCT, PluriSelect Life Science UG & Co. KG, MiltenyiBiotec, Beckman Coulter, Inc and STEMCELL Technologies Inc.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Prevalence of Chronic Diseases
    • 4.2.2 Technological Advancement and Innovation in Cell Isolation
  • 4.3 Market Restraints
    • 4.3.1 Strict Regulations and Compliances for Cell Separation
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Product
    • 5.1.1 Consumables
      • 5.1.1.1 Reagents & kits
      • 5.1.1.2 Beads
      • 5.1.1.3 Disposables
    • 5.1.2 Instruments
      • 5.1.2.1 Centrifuges
      • 5.1.2.2 Flow cytometers
      • 5.1.2.3 Filtration systems
      • 5.1.2.4 Magnetic-activated cell separator systems
  • 5.2 By Type
    • 5.2.1 Human
    • 5.2.2 Animal
  • 5.3 By Application
    • 5.3.1 Research Laboratories and Institutes
    • 5.3.2 Biotechnology and Biopharmaceutical Companies
    • 5.3.3 Others
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle-East and Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle-East and Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Becton Dickinson and Company
    • 6.1.2 GE Healthcare
    • 6.1.3 Merck KgaA
    • 6.1.4 Thermo Fisher Scientific
    • 6.1.5 Bio-Rad Laboratories Inc
    • 6.1.6 Terumo BCT
    • 6.1.7 PluriSelect Life Science UG & Co. KG
    • 6.1.8 MiltenyiBiotec
    • 6.1.9 Beckman Coulter, Inc
    • 6.1.10 STEMCELL Technologies Inc

7 MARKET OPPORTUNITIES AND FUTURE TRENDS